Endpoints NewsExclusive: Top neuroscientist Asa Abeliovich targets ALS, schizophrenia with new startup Leal after $1B Lilly buyout February 7, 2024
Endpoints NewsScoop: Star neuroscientist Asa Abeliovich and OrbiMed are teaming on yet another biotech February 14, 2022
